Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Josephine Strijker

PhD student

Neuroblastoma immunology, immunotherapy and organoid models

Phone +31 88 97 27 677





Josephine will work on investigating the immune environment of neuroblastoma tumors to investigate potential immunotherapies for neuroblastoma patients. In addition, Josephine is engaged in the optimization of neuroblastoma organoid culture.

  • Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In Vitro

    • jul. 2023
    • Ronja, Pscheid, et al
    • Journal of Immunology
  • Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch

    • dec. 2022
    • Annelisa M, Cornel, et al
    • Journal for ImmunoTherapy of Cancer
  • P06.03 T cell mediated killing of neuroblastoma is inhibited by secreted MIF and MDK

    • sep. 2022
    • JGM, Strijker, et al
  • P06.01 αβ-T cells engineered to express γδ-T cell receptors can kill neuroblastoma organoids independent of MHC-I expression

    • okt. 2021
    • JGM, Strijker, et al
  • αβ-T Cells Engineered to Express γδ-T Cell Receptors Can Kill Neuroblastoma Organoids Independent of MHC-I Expression

    • sep. 2021
    • Josephine G.M., Strijker, et al
    • Journal of Personalized Medicine
View all publications